03.01.2014 Views

Financial Report and Registration Document 2010 - Groupe Seb

Financial Report and Registration Document 2010 - Groupe Seb

Financial Report and Registration Document 2010 - Groupe Seb

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

3<br />

CONSOLIDATED FINANCIAL STATEMENTS<br />

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS<br />

The assumptions used – which mainly concern impairment tests on<br />

non-current assets – <strong>and</strong> the sensitivity of reported amounts to changes in<br />

these assumptions are presented in the relevant notes to these consolidated<br />

financial statements, in accordance with IAS 36.<br />

Estimates are adjusted following any change in the circumstances on which<br />

they were based or when any new information comes to light. Actual results<br />

may differ from these estimates <strong>and</strong> assumptions.<br />

The main estimates <strong>and</strong> assumptions used to prepare the consolidated<br />

financial statements concern the measurement of pension <strong>and</strong> other<br />

post-employment benefit obligations (Note 22.1), deferred taxes (Note 1.4.9),<br />

property, plant <strong>and</strong> equipment (Note 1.4.3), intangible assets (Notes 1.4.1 <strong>and</strong><br />

10), investments in associates <strong>and</strong> other investments, impairment of current<br />

assets (Notes 1.4.5 <strong>and</strong> 1.4.6), short <strong>and</strong> long-term provisions (Notes 1.4.10<br />

<strong>and</strong> 1.4.11), certain financial instruments (Note 1.4.4 – Derivative instruments)<br />

<strong>and</strong> share-based payments (Note 1.4.10).<br />

1.4. ACCOUNTING POLICIES AND VALUATION<br />

METHODS<br />

The financial statements of Group companies are prepared in accordance<br />

with local generally accepted accounting principles. They are restated where<br />

necessary to comply with Group accounting policies.<br />

The notes to the consolidated financial statements include analyses of assets<br />

<strong>and</strong> liabilities by maturity where disclosure of this information is required<br />

under IFRS.<br />

The methods used to measure intangible assets, property, plant <strong>and</strong><br />

equipment, inventories <strong>and</strong> trade receivables are described below.<br />

1.4.1. Intangible assets<br />

A) DEVELOPMENT COSTS<br />

Under IAS 38 – Intangible Assets, research costs are recognised as an<br />

expense <strong>and</strong> development costs are recognised as an intangible asset when<br />

the Group can demonstrate (IAS 38, paragraph 57):<br />

its intention to complete the development project;<br />

that it is probable that the expected future economic benefits attributable<br />

to the asset will flow to the Group;<br />

its ability to measure reliably the cost of the asset.<br />

Development costs that do not fulfi l the above criteria are expensed as<br />

incurred.<br />

In the consolidated fi nancial statements, qualifying development costs<br />

incurred after the advance design phase <strong>and</strong> before the manufacturing phase<br />

are recognised as intangible assets.<br />

Development costs are amortised on a straight-line basis over three to<br />

five years, corresponding to the same useful life as that applied to specific<br />

tooling.<br />

B) OTHER INTANGIBLE ASSETS<br />

Software licences <strong>and</strong> internal software development costs are recognised as<br />

intangible assets when it is probable that they will generate future economic<br />

benefits. They are amortised by the straight-line method over periods ranging<br />

from three to five years. Other software licences <strong>and</strong> software development<br />

costs are expensed as incurred.<br />

Patents, licences <strong>and</strong> trademarks with a finite useful life are amortised over<br />

the shorter of the period of legal protection <strong>and</strong> their expected useful life,<br />

not to exceed fifteen years.<br />

Trademarks with an indefinite useful life are not amortised but are tested<br />

for impairment.<br />

C) GOODWILL<br />

Goodwill, corresponding to the excess of the Group’s interest in net fair value<br />

of the identifiable assets <strong>and</strong> liabilities acquired in a business combination<br />

over the consideration transferred, is recognised in the balance sheet as<br />

an asset under “goodwill”. The consideration transferred is measured as<br />

the fair value of assets transferred, equity instruments issued <strong>and</strong> liabilities<br />

incurred by the acquirer to the former owner on the acquisition date, plus any<br />

contingent consideration. In the case of a business combination achieved in<br />

stages, the difference between the carrying amount of the previously held<br />

interest <strong>and</strong> its acquisition-date fair value is recognised directly in profit or<br />

loss on the acquisition date.<br />

For each business combination, any non-controlling interest in the acquiree<br />

may be measured either at fair value on the acquisition date (full goodwill<br />

method) or at the non-controlling interest’s proportionate share of the<br />

acquiree’s identifiable net assets (partial goodwill method).<br />

The fair values provisionally attributed to identifiable assets <strong>and</strong> liabilities,<br />

non-controlling interests measured at fair value <strong>and</strong> the various components<br />

of the consideration transferred may be adjusted for a period of twelve<br />

months after the acquisition date. After that period, any adjustments are<br />

recognised prospectively in profit or loss with no adjustment to goodwill.<br />

Goodwill is not amortised but is tested for impairment at least once a year.<br />

For impairment testing purposes, goodwill is allocated to a Cash-Generating<br />

Unit (CGU), defined as the smallest identifiable group of assets that generates<br />

cash infl ows that are largely independent of the cash infl ows from other<br />

assets or groups of assets<br />

The method used to test CGUs for impairment is described in Note 1.4.3.<br />

When a CGU is found to be impaired, an impairment loss corresponding<br />

to the difference between the carrying amount of the goodwill <strong>and</strong> its<br />

recoverable amount is recognised in “Other operating expense”. Impairment<br />

losses on goodwill are not reversible.<br />

Negative goodwill is recognised directly in the income statement for the<br />

period of acquisition <strong>and</strong> attributed in full to the acquirer.<br />

1.4.2. Property, plant <strong>and</strong> equipment<br />

Property, plant <strong>and</strong> equipment are initially recognised at cost <strong>and</strong> are<br />

depreciated by the straight-line method over their estimated useful lives.<br />

Maintenance <strong>and</strong> repair costs are expensed as incurred.<br />

The main useful lives are as follows:<br />

buildings:<br />

10 to 40 years;<br />

plant <strong>and</strong> machinery:<br />

10 years;<br />

office equipment:<br />

3 to 10 years;<br />

vehicles:<br />

4 to 5 years;<br />

tooling:<br />

1 to 5 years.<br />

Each significant part of an item of property, plant <strong>and</strong> equipment with a useful<br />

life that is different from that of the asset to which it belongs is depreciated<br />

separately. Useful lives are reviewed at regular intervals <strong>and</strong> the effect of<br />

any adjustments – corresponding to a change in accounting estimates – is<br />

applied prospectively.<br />

3<br />

GROUPE SEB<br />

FINANCIAL REPORT AND REGISTRATION DOCUMENT <strong>2010</strong><br />

69

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!